Bilirubin assay

Details Bilirubin assay Bilirubin assay

1982-12-27

1986-01-07

Turk, Arnold

Chemistry: analytical and immunological testing

Heterocyclic carbon compound

Hetero-n

436903, G01N 3372

Patent

active

045634297

ABSTRACT:
An improved conjugated (direct) bilirubin assay comprises treating a sample to be assayed with a buffer having a pH of about 4 to 5 and containing iodide ions thereby decreasing the oxidation of hemoglobin to methemoglobin and preventing conjugated bilirubin from being oxidized to biliverdin. The iodide also prevents the destruction of the azopigment by the hemoglobin. The assay further comprises adding a diazo reagent to the treated sample, incubating the resulting mixture, adding ascorbic acid, alkaline tartrate and a caffeine reagent and then reading the absorbence at 600 nm. The concentration of direct bilirubin is calculated by comparison to the absorbance of unconjugated standard(s) analyzed by a method for total bilirubin. The improved assay is more accurate than prior art methods because hemoglobin interference is negligible. In a preferred embodiment the buffer is sodium acetate buffer having a pH of about 4.75 which contains 3 to 30 grams/L of potassium iodide. A kit containing the acetate buffer is also disclosed.

REFERENCES:
Poon, Clinical Chemistry, 27 (4), 636-637, 1981.
Henry et al., "Clinical Chemistry-Principles and Technics", 2nd Ed., Harper and Row, New York, 1974, pp. 1045-1064.

Affiliated with

Also associated with

Rating

Bilirubin assay does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bilirubin assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bilirubin assay will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-111705